Veralox Therapeutics Company
Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes.
 University System of Maryland.jpeg)
 Innovation Fund.jpg)
Industry:
Early Drug Development, Geroscience
Headquarters:
Frederick, Maryland, United States
Zip:
1-10
Founded Date:
2017-01-01
Employees Number:
1-10
Funding Status:
Early Stage Venture
Acquisitions Number:
13
Investors Number:
13
Total Funding:
22000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-06-16
Last Funding Type:
Series A
Register and Claim Ownership